Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Novospray (0470f4)
- Development stage
- Preclinical
- Lead developer
- Newtricious R&D
- Administration
- Topical
01
Overview
Novospray is an investigational artificial-saliva oral spray developed for symptomatic relief of xerostomia in people with Sjögren's syndrome. In a randomized crossover study sponsored by the Academic Centre for Dentistry Amsterdam, participants used Novospray and a placebo spray for two-week treatment periods separated by a washout period. The product is intended to lubricate and moisten the oral cavity as a saliva substitute; no specific pharmacologic active ingredient, molecular target, or target-mediated mechanism was publicly identified. ([onderzoekmetmensen.nl](https://onderzoekmetmensen.nl/nl/node/20248/pdf))
- Brand names
- Novospray
- Other names
- NOVOSPRAY
Beyond the preview
Go deeper on Novospray (0470f4).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novospray (0470f4).